ST. PETERSBURG (Sputnik) — The second phase of Ebola vaccine clinical tests is scheduled to wrap up on December 8, the head of the Russian federal health and epidemic watchdog Rospotrebnadzor said Thursday.
"We should complete the second phase on December 8 and then submit documents for registration," Anna Popova told reporters. "Everything is going as planned and we see very good results."
The first phase of clinical trials passed with 100-percent effectiveness after two inoculations in May. The vaccination against Ebola was created by Russia’s Vektor scientific center.
The most recent Ebola outbreak started in December 2013 in Guinea and later spread to Liberia and Sierra Leone. The virus has claimed the lives of over 11,000 people, according to World Health Organization (WHO) estimates.
